Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
5.58
-0.57 (-9.27%)
Jul 29, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Pharma Tests and Services | 50.94M | Log In | Log In | Log In | Log In | Upgrade |
Pharma Tests and Services Growth | 59.66% | Log In | Log In | Log In | Log In | Upgrade |
Enterprise | 25.36M | Log In | Log In | Log In | Log In | Upgrade |
Enterprise Growth | -20.06% | Log In | Log In | Log In | Log In | Upgrade |
Population Sequencing | 7.43M | Log In | Log In | Log In | Log In | Upgrade |
Population Sequencing Growth | -21.06% | Log In | Log In | Log In | Log In | Upgrade |
Clinical Diagnostic | 759.00K | Log In | Log In | Log In | Log In | Upgrade |
Other | 122.00K | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -72.02% | Log In | Log In | Log In | Log In | Upgrade |
United States Veterans Affair's Million Veteran Program | - | Log In | Log In | Log In | Log In | Upgrade |
United States Veterans Affair's Million Veteran Program Growth | - | Log In | Log In | Log In | Log In | Upgrade |
All Other Customers | - | Log In | Log In | Log In | Log In | Upgrade |
All Other Customers Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
United States | 81.23M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 22.83% | Log In | Log In | Log In | Log In | Upgrade |
International | 3.38M | Log In | Log In | Log In | Log In | Upgrade |
International Growth | -53.94% | Log In | Log In | Log In | Log In | Upgrade |